Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,863
Sort by:
2015 European Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 15,760.00
... business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy ... basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...
September 2015
820 pages
2015 France Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 5,440.00
... forecasts, supplier shares) $3,950. '2015 France Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging ...
September 2015
585 pages
2015 Germany Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 5,440.00
... forecasts, supplier shares) $3,950. '2015 Germany Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging ...
September 2015
585 pages
2015 Italy Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 5,440.00
... forecasts, supplier shares) $3,950. '2015 Italy Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging ...
September 2015
570 pages
2015 Japan Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 6,080.00
... forecasts, supplier shares) $4,300. '2015 Japan Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer diagnostics markets; reviews current and emerging ...
September 2015
590 pages
2015 Spain Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 5,440.00
... forecasts, supplier shares) $3,950. '2015 Spain Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging ...
September 2015
565 pages
2015 UK Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 5,440.00
... forecasts, supplier shares) $3,950. '2015 UK Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging ...
September 2015
565 pages
2015 US Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 7,840.00
... forecasts, supplier shares) $6,400. '2015 US Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging ...
September 2015
620 pages
2015 World AFP Testing Market: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Supplier Shares, Country Volume and Sales Segment Forecasts, Competitive Strategies
US$ 3,480.00
... assays and the rapid market expansion worldwide. This report presents a detailed analysis of the Alpha-fetoprotein testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test ...
September 2015
248 pages
2015 Global Cancer Diagnostics Market: Profiles of Leading Suppliers
US$ 2,000.00
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages
September 2015
80 pages
2015-2019 Europe Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Spain, UK
US$ 15,760.00
... and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. RationaleThe cancer diagnostics market is on the ... of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...
September 2015
820 pages
2015-2019 Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Country Sales Forecasts, and Strategic Profiles of Leading Suppliers
US$ 6,000.00
... cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer ... significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new ...
September 2015
510 pages
Global Cancer Vaccine Market & Clinical Trial Insight
US$ 4,000.00
... cancer vaccines will hit the shelf in coming years. “Global Cancer Vaccine Market & Clinical Trial Insight” Report Highlights: Global Cancer Market Overview Emergence of Personalized Cancer Vaccines Platforms for Cancer Vaccines Delivery Mechanism of Cancer Vaccines Global Cancer Vaccines Clinical ...
September 2015
750 pages
Global NDDS in Cancer Therapy Industry 2015 Market Research Report
US$ 2,850.00
2015 Global NDDS in Cancer Therapy Industry Report is a professional and in-depth research report on the world's major regional market conditions of the NDDS in Cancer Therapy industry, focusing on the ... with: 1.) basic information; 2.) the Asia NDDS in Cancer Therapy industry; 3.) the North American NDDS in Cancer Therapy industry; 4.) the European NDDS in Cancer Therapy industry; 5.) market entry and investment feasibility ...
August 2015
168 pages
2015-2019 France Cancer Diagnostics Industry: Market Segmentation Analysis - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs
US$ 5,360.00
... specific information needs and budget. 2015-2019 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in France. Business Opportunities ...
August 2015
585 pages
2015-2019 Germany Cancer Diagnostics Industry: Market Segmentation Analysis - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs, POC Locations
US$ 5,360.00
... specific information needs and budget. 2015 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines ... universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Germany. Business Opportunities ...
August 2015
585 pages
2015-2019 Italy Cancer Diagnostics Industry: Market Segmentation Analysis - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs
US$ 5,360.00
... specific information needs and budget. 2015-2019 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Italy. Business Opportunities ...
August 2015
570 pages
